Kimia Biosciences

38.80
-2.20
(-5.37%)
Market Cap
183.59 Cr
EPS
-1.12
PE Ratio
20.60
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
58.39
52 Week Low
37.33
PB Ratio
24.40
Debt to Equity
16.69
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,707.80
#1 4,09,758.43
34.33
#1 49,887.20
12.06
#1 9,648
13.77
47.60
5,700.50
1,51,330.36
71.83
8,184.00
0.89
1,600
#1 64.53
47.92
1,467.80
1,18,541.72
23.68
26,520.70
14.17
4,155
47.38
50.89
3,194.60
1,08,119.78
56.84
10,785.70
11.59
1,656
13.54
45.29
2,419.60
99,827.50
47.52
10,615.60
19.57
1,942
-16.38
48.68
1,142.10
95,303.15
#1 17.23
28,905.40
12.36
5,578
1.69
40.66
1,998.40
91,235.14
31.34
20,141.50
#1 19.94
1,936
38.82
46.62
869.45
87,487.01
19.27
19,831.50
13.82
3,831
29.92
44.56
1,127.60
65,491.19
17.83
29,559.20
17.55
3,169
-10.04
41.61
30,235.00
64,247.26
47.10
6,097.20
10.80
1,201
16.01
48.36
Growth Rate
Revenue Growth
-17.89 %
Net Income Growth
-43.62 %
Cash Flow Change
314.62 %
ROE
836.82 %
ROCE
-61.45 %
EBITDA Margin (Avg.)
-137.59 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
2
0
2
77
95
107
135
126
130
107
112
Expenses
4
4
2
74
88
102
124
124
134
105
95
EBITDA
-1
-3
-0
3
7
5
11
2
-4
1
17
Operating Profit %
-110 %
-1,759 %
-67 %
3 %
6 %
4 %
6 %
1 %
-4 %
-0 %
15 %
Depreciation
0
0
0
1
1
2
2
3
3
3
3
Interest
0
1
0
1
2
3
3
4
4
5
4
Profit Before Tax
-2
-4
-1
2
4
1
6
-5
-12
-7
10
Tax
0
0
-0
-0
0
-0
0
-1
-3
-2
0
Net Profit
-2
-4
-1
2
4
1
5
-4
-9
-5
9
EPS in ₹
-2.31
-5.49
-1.26
1.14
2.64
0.33
1.08
-0.78
-1.98
-1.12
2.00

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
5
4
12
58
65
86
107
110
121
100
Fixed Assets
3
3
7
13
16
18
28
35
34
32
Current Assets
1
1
2
43
48
61
72
73
83
61
Capital Work in Progress
0
0
3
3
2
6
6
0
1
1
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
1
1
2
43
48
62
73
74
87
68
Total Liabilities
5
4
12
58
65
86
107
110
121
100
Current Liabilities
4
1
7
31
30
39
51
62
76
69
Non Current Liabilities
1
7
9
25
29
34
37
33
40
30
Total Equity
0
-4
-5
2
6
13
18
15
6
0
Reserve & Surplus
-7
-11
-12
-2
2
9
14
10
1
-4
Share Capital
7
7
7
2
2
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
1
-1
0
0
-0
0
0
Investing Activities
0
-0
-6
-2
-2
-9
-14
-1
-3
-2
Operating Activities
0
-6
-1
-7
-3
0
6
8
-7
15
Financing Activities
-0
6
7
10
4
9
8
-8
10
-13

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
74.94 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
0.38 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.16 %
23.15 %
23.15 %
23.09 %
23.16 %
0.00 %
23.20 %
23.11 %
23.10 %
23.04 %
23.04 %
23.04 %
23.05 %
23.05 %
23.03 %
22.94 %
Others
1.52 %
1.52 %
1.52 %
1.59 %
1.51 %
24.68 %
1.48 %
1.57 %
1.58 %
1.64 %
1.64 %
1.64 %
1.63 %
1.63 %
1.65 %
1.74 %
No of Share Holders
11,912
12,192
12,173
12,212
12,510
12,454
12,399
12,243
12,201
12,147
12,118
12,063
12,110
12,023
12,179
12,231

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Disclosure Under Regulation 31(4) & (5) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011 For The Financial Year Ended March 31 202510 days ago
Disclosure Under Regulation 31(4) & (5) Of SEBI (Substantial Acquisition Of Shares & Takeovers) Regulations 2011 For The Financial Year Ended March 31 202510 days ago
Closure of Trading WindowMar 26, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateMar 06, 2025
Non-Applicability Of Corporate Governance Report As Per Regulation 27(2) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Pursuant To Regulation 15 Of SEBI (Listing ObligatioFeb 21, 2025
Newspaper Publication Of Un-Audited Financial Results For The Quarter And Nine Months Ended On 31St December 2024 Under Regulation 47 Of SEBI (Listing Obligations And Disclosure Requirements) RegulatiFeb 14, 2025
Integrated Filing (Financial)Feb 13, 2025
Integrated Filing (Financial) For The Quarter And Nine Months Ended 31St December 2024Feb 13, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday February 13 2025 For Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024 Along With The LimitedFeb 13, 2025
Board Meeting Intimation for Intimation Of Board Meeting Dated February 13 2025Feb 07, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 30, 2025
Compliance Under Regulation 76 Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended 31St December 2024Jan 29, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 28, 2025
Compliance Under Regulation 76 Of SEBI (Depositories And Participants) Regulations 2018Jan 28, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJan 28, 2025
Appointment of Company Secretary and Compliance OfficerJan 28, 2025
Regulation 13(3) For The Statement Of Investor ComplaintsJan 22, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2025
Scrutiniser ReportDec 31, 2024
Chairman SpeechDec 30, 2024
Closure of Trading WindowDec 30, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMDec 30, 2024
Annual Report_2023-24Dec 13, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 11, 2024
Correction In The Intimation Of 31St Notice Of AGM Dated 30.12.2024Dec 11, 2024
AGM Notice For The FY 2023-24Dec 09, 2024
31St Annual General Meeting ('AGM') Of The Company Is Scheduled To Be Held On Monday, December 30, 2024 At 04.00 Pm (IST) Through Video Conferencing/ Other Audio Visual Means ('VC/OAVM')Dec 07, 2024
Board Meeting Outcome for Revised Outcome Of Board Meeting Dated 05.12.2024Dec 06, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And DisclosureRequirements), Regulations 2015.Dec 05, 2024
Board Meeting Intimation for Intimation For Board Meeting To Approve Directors Report And AGM Notice For The FY Ended March 31, 2024.Nov 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 18, 2024
Results For The Half Financial Year September 2024Nov 14, 2024
Results_Financial Statement Ending On 30 September 2024Nov 14, 2024
Appointment of Company Secretary and Compliance OfficerNov 14, 2024
Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015.Nov 14, 2024
Board Meeting Intimation for Notice Of Board Meeting - November 14, 2024Nov 12, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 10, 2024
Closure of Trading WindowSep 30, 2024
Clarification LetterSep 17, 2024
Intimation Of Approval For Extension Of Time To Conduct Annual General MeetingSep 16, 2024
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Award Of ContractSep 16, 2024
Unaudited Financial Results For The Quarter Ended On 30Th June2024Aug 20, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 20, 2024
Unaudited Quarterly Financial Results For The Quarter Ended On 30Th June,2024.Aug 20, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 12, 2024
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011Aug 12, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerAug 12, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 12, 2024
Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For Filing Of Quality Product For Benfotiamine In European Union- Bulgaria.Aug 09, 2024
Board Meeting Intimation for Intimation Of Board Meeting For Adoption Of Un-Audited Financial Results For The Quarter Ended June 30, 2024.Aug 06, 2024

Technical Indicators

RSI(14)
Neutral
44.46
ATR(14)
Less Volatile
2.78
STOCH(9,6)
Neutral
20.39
STOCH RSI(14)
Neutral
22.80
MACD(12,26)
Bearish
-0.38
ADX(14)
Weak Trend
17.96
UO(9)
Bearish
42.64
ROC(12)
Downtrend And Accelerating
-6.48
WillR(14)
Neutral
-69.83